Athlone-based pharmaceutical group Elan has today reported net income of $52.3 million for its fiscal third quarter compared to a loss of $83.5 million last year.For the third quarter of 2009, Elan reported adjusted earnings before interest, tax, depreciation ...
[Irish Times - 10/21/2009]